[86] reported that RG7834, a novel oral HBV gene expression inhibitor, could decrease the amounts of viral proteins and reduce viremia. RG7834 is a small-molecule compound belonging towards the dihydroquinolizinones chemical class comparable to RNAi but as a result of a unique mechanism. Because it provides a minimal oral bioavailability https://elderx111vnf2.wikififfi.com/user